Global Transcatheter Cardiac Valve Replacement Market Size Study, By Product, By Indication, By End User, and Regional Forecasts 2022-2032

Description

The Global Transcatheter Cardiac Valve Replacement (THVR) Market, valued at USD 6.54 billion in 2023, is anticipated to grow significantly with a CAGR of 14.8% over the forecast period of 2024 to 2032. The market's expansion is driven by an increasing demand for minimally invasive surgeries, the growing elderly population suffering from cardiovascular diseases, and advancements in TAVR technologies that improve patient outcomes and safety profiles. Transcatheter Aortic Valve Replacement (TAVR) is increasingly recognized as a less invasive alternative for patients with severe aortic stenosis or regurgitation who are deemed too high-risk for open-heart surgery.

The growing adoption of second-generation TAVR devices, which provide improved safety and lower the risks of paravalvular regurgitation and valve embolization, is expected to propel the market. Technological advancements, such as TAVR valves with smaller diameters, better sealing, and greater precision, are anticipated to further boost market growth. Moreover, ongoing clinical trials and innovations in the TAVR space present significant opportunities for market players to introduce advanced bioprosthetic valves.

North America is expected to dominate the market, driven by a well-established healthcare infrastructure, the presence of leading market players, and a growing elderly population. Europe is projected to follow, with increasing adoption of minimally invasive cardiovascular procedures and strong government support for advanced cardiac therapies. The Asia-Pacific region is anticipated to exhibit the fastest growth due to rising healthcare investments, increasing prevalence of cardiovascular diseases, and improvements in healthcare infrastructure.

Key market players include:

Abbott
Edwards Lifesciences Corporation
Medtronic
Boston Scientific Corporation
JenaValve Technology, Inc.
Meril Life Sciences
Sahajanand Medical Technologies Limited
MicroPort Scientific Corporation
Venus Medtech (Hangzhou) Inc.
Suzhou Jiecheng Medical Technology Co. Ltd.
Peijia Medical Limited
Blue Sail Medical Co., Ltd.

The detailed segments and sub-segments of the market are explained below:

By Product:

Self-Expandable Transcatheter Aortic Valves
Balloon-Expandable Transcatheter Aortic Valves
Mechanically Expanded Transcatheter Aortic Valves

By Indication:

Severe Aortic Valve Stenosis
Valve-in-Valve Procedures (Failed Bioprosthesis)
Aortic Regurgitation

By End User:

Hospitals
Independent Cardiac Catheterization Labs
Ambulatory Surgical Centres

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Years considered for the study are as follows:

Historical year: 2022
Base year: 2023
Forecast period: 2024 to 2032

Key Takeaways:

Market estimates and forecasts for 10 years (2022-2032)
Detailed regional analysis with country-level breakdowns
Competitive landscape with information on major market players
Analysis of key strategies and recommendations for future market approaches
Emphasis on technological advancements and their impact on market dynamics

Chapter 1: Global Transcatheter Cardiac Valve Replacement Market Executive Summary

1.1. Global Transcatheter Cardiac Valve Replacement Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Indication
- 1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendations & Conclusion

Chapter 2: Global Transcatheter Cardiac Valve Replacement Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply-Side Analysis
  - 2.3.3.1. Regulatory Environment
  - 2.3.3.2. Technological Advancements
- 2.3.4. Demand-Side Analysis
  - 2.3.4.1. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3: Global Transcatheter Cardiac Valve Replacement Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising Demand for Minimally Invasive Procedures
- 3.1.2. Technological Advancements in TAVR Devices
- 3.1.3. Growing Prevalence of Cardiovascular Diseases
3.2. Market Challenges
- 3.2.1. High Costs of TAVR Procedures
- 3.2.2. Limited Awareness in Developing Regions
- 3.2.3. Regulatory and Reimbursement Challenges
3.3. Market Opportunities
- 3.3.1. Ongoing Clinical Research and Innovations
- 3.3.2. Expanding Healthcare Infrastructure in Emerging Markets

Chapter 4: Global Transcatheter Cardiac Valve Replacement Market Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Analyst Recommendations & Conclusion

Chapter 5: Global Transcatheter Cardiac Valve Replacement Market Size & Forecasts by Product (2022-2032)

5.1. Segment Dashboard
5.2. Global Transcatheter Cardiac Valve Replacement Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Self-Expandable Transcatheter Aortic Valves
- 5.2.2. Balloon-Expandable Transcatheter Aortic Valves
- 5.2.3. Mechanically Expanded Transcatheter Aortic Valves

Chapter 6: Global Transcatheter Cardiac Valve Replacement Market Size & Forecasts by Indication (2022-2032)

6.1. Segment Dashboard
6.2. Global Transcatheter Cardiac Valve Replacement Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Severe Aortic Valve Stenosis
- 6.2.2. Valve-in-Valve Procedures (Failed Bioprosthesis)
- 6.2.3. Aortic Regurgitation

Chapter 7: Global Transcatheter Cardiac Valve Replacement Market Size & Forecasts by End User (2022-2032)

7.1. Segment Dashboard
7.2. Global Transcatheter Cardiac Valve Replacement Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Hospitals
- 7.2.2. Independent Cardiac Catheterization Labs
- 7.2.3. Ambulatory Surgical Centres

Chapter 8: Global Transcatheter Cardiac Valve Replacement Market Size & Forecasts by Region (2022-2032)

8.1. North America Transcatheter Cardiac Valve Replacement Market
- 8.1.1. U.S. Transcatheter Cardiac Valve Replacement Market
  - 8.1.1.1. Product breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Indication breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Transcatheter Cardiac Valve Replacement Market
8.2. Europe Transcatheter Cardiac Valve Replacement Market
- 8.2.1. UK Transcatheter Cardiac Valve Replacement Market
- 8.2.2. Germany Transcatheter Cardiac Valve Replacement Market
- 8.2.3. France Transcatheter Cardiac Valve Replacement Market
- 8.2.4. Spain Transcatheter Cardiac Valve Replacement Market
- 8.2.5. Italy Transcatheter Cardiac Valve Replacement Market
- 8.2.6. Rest of Europe Transcatheter Cardiac Valve Replacement Market
8.3. Asia-Pacific Transcatheter Cardiac Valve Replacement Market
- 8.3.1. China Transcatheter Cardiac Valve Replacement Market
- 8.3.2. India Transcatheter Cardiac Valve Replacement Market
- 8.3.3. Japan Transcatheter Cardiac Valve Replacement Market
- 8.3.4. Australia Transcatheter Cardiac Valve Replacement Market
- 8.3.5. South Korea Transcatheter Cardiac Valve Replacement Market
- 8.3.6. Rest of Asia-Pacific Transcatheter Cardiac Valve Replacement Market
8.4. Latin America Transcatheter Cardiac Valve Replacement Market
- 8.4.1. Brazil Transcatheter Cardiac Valve Replacement Market
- 8.4.2. Mexico Transcatheter Cardiac Valve Replacement Market
- 8.4.3. Rest of Latin America Transcatheter Cardiac Valve Replacement Market
8.5. Middle East & Africa Transcatheter Cardiac Valve Replacement Market
- 8.5.1. Saudi Arabia Transcatheter Cardiac Valve Replacement Market
- 8.5.2. South Africa Transcatheter Cardiac Valve Replacement Market
- 8.5.3. Rest of Middle East & Africa Transcatheter Cardiac Valve Replacement Market

Chapter 9: Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Abbott
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Edwards Lifesciences Corporation
- 9.3.3. Medtronic
- 9.3.4. Boston Scientific Corporation
- 9.3.5. JenaValve Technology, Inc
- 9.3.6. Meril Life Sciences
- 9.3.7. Sahajanand Medical Technologies Limited
- 9.3.8. MicroPort Scientific Corporation
- 9.3.9. Venus Medtech (Hangzhou) Inc.
- 9.3.10. Suzhou Jiecheng Medical Technology Co. Ltd.
- 9.3.11. Peijia Medical Limited
- 9.3.12. Blue Sail Medical Co., Ltd.

Chapter 10: Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes